RecruitingNCT05826457
North American Prodromal Synucleinopathy Consortium Stage 2
Sponsor
Washington University School of Medicine
Enrollment
500 participants
Start Date
Aug 12, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This study will enroll participants with idiopathic REM sleep behavior disorder (RBD) and healthy controls for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is following people who have REM sleep behavior disorder — a condition where people physically act out their dreams while sleeping — because this condition can be an early warning sign of Parkinson's disease or a related brain disorder. The study also enrolls healthy matched controls for comparison.
**You may be eligible if...**
- You are over 18 years old
- You have been diagnosed with REM sleep behavior disorder (confirmed by a sleep study)
- OR you are a healthy volunteer matched by age, sex, and race to someone with REM sleep behavior disorder
- You are willing to undergo brain imaging and a lumbar puncture (spinal fluid test)
**You may NOT be eligible if...**
- You already have a diagnosis of Parkinson's disease, dementia, or multiple system atrophy (unless you previously participated in the first stage of this study)
- You have narcolepsy
- You have an active psychiatric or medical condition that would make participation unsafe
- You have a contraindication to MRI or lumbar puncture
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(9)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05826457
Related Trials
A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease
NCT071577351 location
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS
NCT065536254 locations
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
NCT0447778550 locations
Neurophysiology of Reward Signaling in Parkinson's Disease
NCT074092071 location
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
NCT0366460919 locations